Novartis Exec Scherer Joins Cellectis as Deputy Chief Medical Officer

Xconomy New York — 

Stefan Scherer has been appointed senior vice president of clinical development and deputy chief medical officer of Cellectis (NASDAQ: CLLS). He comes to the French cell therapy developer from Novartis (NYSE: NVS), where he was head of early development, strategy, and innovation for U.S. oncology. Scherer will be based in New York. Cellectis is developing new cancer immunotherapies based on gene-edited T-cells.